Attenuation of estrous cycle-dependent marble burying in female rats by acute treatment with progesterone and antidepressants

[1]  P. Popik,et al.  Increased depressive-like traits in an animal model of premenstrual irritability , 2007, Hormones and Behavior.

[2]  T. Lovick,et al.  Plasticity of GABAA receptor subunit expression during the oestrous cycle of the rat: implications for premenstrual syndrome in women , 2006, Experimental physiology.

[3]  D. Mishell.  Premenstrual disorders: epidemiology and disease burden. , 2005, The American journal of managed care.

[4]  K. Yonkers,et al.  Pretreatment pattern of symptom expression in premenstrual dysphoric disorder. , 2005, Journal of affective disorders.

[5]  G. C. Wolf,et al.  Efficacy of progesterone vaginal suppositories in alleviation of nervous symptoms in patients with premenstrual syndrome , 1995, Journal of Assisted Reproduction and Genetics.

[6]  D. Blanchard,et al.  The rat exposure test: a model of mouse defensive behaviors , 2004, Physiology & Behavior.

[7]  E. Freeman.  Luteal Phase Administration of Agents for the Treatment of Premenstrual Dysphoric Disorder , 2004, CNS drugs.

[8]  L. Kahn,et al.  The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD) , 2003, Psychoneuroendocrinology.

[9]  L. Kahn,et al.  Pharmacotherapy of premenstrual syndromes and premenstrual disphoric disorder: current practices , 2002, Expert opinion on pharmacotherapy.

[10]  F. K. Marcondes,et al.  Determination of the estrous cycle phases of rats: some helpful considerations. , 2002, Brazilian journal of biology = Revista brasleira de biologia.

[11]  D. Marazziti,et al.  Do animal models of anxiety predict anxiolytic-like effects of antidepressants? , 2002, Psychopharmacology.

[12]  A. Walf,et al.  Changes in Progesterone Metabolites in the Hippocampus Can Modulate Open Field and Forced Swim Test Behavior of Proestrous Rats , 2002, Hormones and Behavior.

[13]  M. Millan,et al.  Stereospecific blockade of marble-burying behaviour in mice by selective, non-peptidergic neurokinin1 (NK1) receptor antagonists , 2002, Neuropharmacology.

[14]  S. Hartlage,et al.  Toward the Content Validity of Premenstrual Dysphoric Disorder: Do Anger and Irritability More than Depressed Mood Represent Treatment-Seekers' Experiences? , 2002, Psychological reports.

[15]  G. Bagdy,et al.  Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. , 2001, The international journal of neuropsychopharmacology.

[16]  F. K. Marcondes,et al.  Estrous cycle influences the response of female rats in the elevated plus-maze test , 2001, Physiology & Behavior.

[17]  K. Merikangas,et al.  The epidemiology of perimenstrual psychological symptoms , 2001, Acta psychiatrica Scandinavica.

[18]  M. Papp,et al.  S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine. , 2001, The Journal of pharmacology and experimental therapeutics.

[19]  J. Levine,et al.  Anxiety disorders and major depression, together or apart , 2001, Depression and anxiety.

[20]  M. Steiner,et al.  Diagnosis and treatment of premenstrual dysphoric disorder: an update. , 2000, International clinical psychopharmacology.

[21]  E. Eriksson.  Serotonin reuptake inhibitors for the treatment of premenstrual dysphoria. , 1999, International clinical psychopharmacology.

[22]  Alessandra Valentini,et al.  Investigative burying by laboratory mice may involve non-functional, compulsive, behaviour , 1998, Behavioural Brain Research.

[23]  D. Rubinow,et al.  Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. , 1998, The New England journal of medicine.

[24]  D. Rubinow,et al.  Hormone measures in reproductive endocrine-related mood disorders: diagnostic issues. , 1998, Psychopharmacology bulletin.

[25]  H. Nakai,et al.  Effect of 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole HCl (MKC-242), a novel 5-HT1A-receptor agonist, on aggressive behavior and marble burying behavior in mice. , 1998, Japanese journal of pharmacology.

[26]  J. Smoller,et al.  Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. , 1997, The Journal of clinical psychiatry.

[27]  M. Steiner,et al.  Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria. , 1997, Psychopharmacology bulletin.

[28]  G. Dı́az-Véliz,et al.  Effects of the estrous cycle and ovarian hormones on behavioral indices of anxiety in female rats , 1996, Psychoneuroendocrinology.

[29]  M. Marván,et al.  Clomipramine modifies fluctuations of forced swimming immobility in different phases of the rat estrous cycle. , 1996, Archives of medical research.

[30]  P. Magill.  Investigation of the efficacy of progesterone pessaries in the relief of symptoms of premenstrual syndrome. progesterone Study Group. , 1995, The British journal of general practice : the journal of the Royal College of General Practitioners.

[31]  A. Fernández-Guasti,et al.  Flumazenil blocks the anxiolytic action of allopregnanolone. , 1995, European journal of pharmacology.

[32]  K. Rickels,et al.  A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. , 1995, JAMA.

[33]  Y. Ichimaru,et al.  5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. , 1995, Japanese journal of pharmacology.

[34]  D. Bitrán,et al.  Anxiolytic Effect of Progesterone is Mediated by the Neurosteroid Allopregnanolone at Brain GABAA Receptors , 1995, Journal of neuroendocrinology.

[35]  I. Gyertyán,et al.  Analysis of the marble burying response: marbles serve to measure digging rather than evoke burying , 1995, Behavioural pharmacology.

[36]  A. Fernández-Guasti,et al.  Changes in burying behavior during the estrous cycle: Effect of estrogen and progesterone , 1992, Psychoneuroendocrinology.

[37]  D. Rubinow,et al.  The Premenstrual Syndrome: New Views , 1992 .

[38]  E. Love,et al.  The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: attributable risk and risk factors. , 1992, Journal of clinical epidemiology.

[39]  T. Bäckström,et al.  Premenstrual syndrome--psychiatric or gynaecological disorder? , 1991, Annals of medicine.

[40]  S. Handley,et al.  Effects of 5‐HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents , 1991, British journal of pharmacology.

[41]  S. Handley,et al.  Evaluation of marble-burying behavior as a model of anxiety , 1991, Pharmacology Biochemistry and Behavior.

[42]  J. Endicott,et al.  Treatment of premenstrual dysphoria with alprazolam. A controlled study. , 1990, Archives of general psychiatry.

[43]  D. McTavish,et al.  Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder. , 1990, Drugs.

[44]  H. Berendsen,et al.  Animal models for anxiety and response to serotonergic drugs. , 1989, Psychopathology.

[45]  J. Lefevre,et al.  Reproductive senescence in female rats: a longitudinal study of individual differences in estrous cycles and behavior. , 1988, Biology of reproduction.

[46]  T. Insel,et al.  Drug treatment of obsessive-compulsive disorder. , 1987, Journal of affective disorders.

[47]  M. Kawaminami,et al.  Preovulatory secretion of progesterone, luteinizing hormone, and prolactin in 4-day and 5-day cycling rats. , 1987, Biology of reproduction.

[48]  C. Broekkamp,et al.  Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice. , 1986, European journal of pharmacology.

[49]  D. Treit.  Animal models for the study of anti-anxiety agents: A review , 1985, Neuroscience & Biobehavioral Reviews.

[50]  L. Dennerstein,et al.  Progesterone and the premenstrual syndrome: a double blind crossover trial. , 1985, British medical journal.

[51]  Raymond Greene,et al.  The Premenstrual Syndrome , 1953, British Journal of Psychiatry.

[52]  J. Pinel,et al.  Effect of septal lesions on conditioned defensive burying , 1981, Physiology & Behavior.

[53]  J. Pinel,et al.  Conditioned and unconditioned defensive burying in the rat , 1979 .

[54]  N. Schwartz,et al.  Measurement of serum steroid and gonadotropin levels and uterine and ovarian variables throughout 4 day and 5 day estrous cycles in the rat. , 1979, Biology of reproduction.

[55]  D. Treit.  Burying as a defensive response in rats , 1978 .

[56]  J. D. Neill,et al.  The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gonadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. , 1975, Endocrinology.

[57]  Torbjörn Bäckström,et al.  Estrogen and progesterone in plasma in relation to premenstrual tension. , 1974, Journal of steroid biochemistry.

[58]  N. Schwartz.  ACUTE EFFECTS OF OVARIECTOMY ON PITUITARY LH, UTERINE WEIGHT, AND VAGINAL CORNIFICATION. , 1964, The American journal of physiology.